Scientists use optogenetics to reactivate memories that could not otherwise be retrieved.
Trying to be creative may actually inhibit your ability to do so, according to a new study by researchers at Stanford University.
Study of zebrafish reveals how dysfunction of SHANK3 or SYNGAP1 genes play a role in the development of Autism Spectrum Disorder.
Degeneration of the white matter of the brain may be an early marker of specific types of Alzheimer's disease (AD), including early-onset AD, according to results of a new study published in the journal Radiology.
Researchers have identified a master genetic regulator that could account for faulty brain functions that contribute to schizophrenia.
A gene essential to the production of pain-sensing neurons in humans has been identified by an international team of researchers. The discovery, reported in the journal Nature Genetics, could have implications for the development of new methods of pain relief.
Researchers have figured out how to create spheres of neuronal cells resembling the cerebral cortex, making functional human brain tissue available for the first time to study neuropsychiatric diseases such as autism and schizophrenia
Sticky plaque gets the most attention, but now healthy seniors at risk of Alzheimer's are letting scientists peek into their brains to see if another culprit is lurking.
Certain proteins may slow the devastating memory loss caused by Alzheimer’s disease, according to a study.
Edward Boyden develops techniques to study the brain, and how it operates, in finer detail.
A new study has found that Naltrexone, a drug used to treat alcoholism, may also be a promising treatment for addiction to methamphetamine.
A team of neuroscientists has identified a part of the brain exclusively devoted to processing speech. Its findings point to the superior temporal sulcus (STS), located in the temporal lobe, and help settle a long-standing debate about role-specific neurological functions.
Whether you’re brainy, brawny or both, you may someday benefit from a drug found to rejuvenate aging brain and muscle tissue.
In case you missed any exciting news on Bioscience Technology last week, here is a round-up of the top five most popular stories.
Adults over 50 who have persistent symptoms of depression may have twice the risk of stroke as those who do not, according to a new study led by researchers at Harvard T.H. Chan School of Public Health and UC San Francisco. Researchers found that stroke risk remains higher even after symptoms of depression go away, particularly for women.
Evidence has long suggested multiple sclerosis (MS) is an autoimmune disease, but researchers have been puzzled because they found the same T cells that attack the myelin sheathing around nerve cells in MS patients are present in healthy subjects as well.
To the nearly 2 million people in the United States living with the loss of a limb, including U.S. military veterans, prosthetic devices provide restored mobility, yet lack sensory feedback. A team of engineers and researchers at Washington University in St. Louis is working to change that so those with upper limb prosthetics can feel hot and cold and the sense of touch through their prosthetic hands.
Smokers who are able to quit might actually be hard-wired for success, according to a study from Duke Medicine.
A team of neuroscientists and bioengineers have created a miniature, fiber-optic microscope designed to peer deeply inside a living brain.
Scientists find a single molecule that controls the fate of mature sensory neurons.
Researchers are seeking to make computer brains smarter by making them more like our own.
Scientists have discovered that a brain protein has a key role in controlling binge drinking in animal models. They found that deleting the gene for this protein in mice ramped up alcohol consumption and prevented the brain from signaling the rewarding properties of alcohol.
More than 25 million people rely on Adderall and other similar drugs to help treat narcolepsy, depression and attention deficit and hyperactivity disorder (ADHD). But how does amphetamine, the active ingredient in Adderall, work? This week, Reactions from the American Chemical Society explains how amphetamine helps you focus.
Research sheds light on how addictive drugs interfere with the dopamine transporter, expected to usher in long-sought advances in treatments
It has been hailed as the equivalent of Google Maps for the human body by The New York Times, and now the award-winning mobile-friendly platform BioDigital Human is looking to change the way healthcare information is shared, consumed and understood.